/Investor DB

Spur Capital Partners — Full Portfolio

3 tracked investments · listed companies and verified rows first

Neurona Therapeuticsneuronatherapeutics.cominApr 2025 · $102M

Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system.

BiotechDeep TechHealthtechSouth San Francisco, US

Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Chief Financial Officer and Chief Business Officer)inCatherine Priest(Chief Development Officer)inGautam Banik(Chief Technology Officer)inEduardo Dunayevich(Chief Medical Officer)inArnold Kriegstein(Director)

Co-investorsBerkeley FrontierIaso VenturesThe Column GroupViking GlobalYsios CapitalAlexandria+8 more

Rodeo Region™bowrivercapital.com

Bow River Capital is a multi-asset investment firm that manages capital across private equity, venture capital, private credit, real estate, and software growth equity strategies.

Enterprise SoftwareFintechSector Agnostic

Blair E. Richardson(Chief Executive Officer)Jane C. Ingalls(President, Chief Operating Officer)Mark Hantho(Executive Chairman)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Acesis

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.